Hence, it is likely that augmenting the expression level of JMJD5 in tumor cells through the uptake of exosomes, subsequently facilitating the degradation of intracellular EGFR, represents a novel tumor-suppressive mechanism of JMJD5. The gene discussed is EGFR; the disease is neoplasm.